Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1107 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Pierre Fabre–BioSerenity: medical device, 201805– collab €na develop + marketing connected device for managing urinary incontinence 2018-05-14
Harvard Univ–Cellectis: gene editing technology, 201805– collab Wyss Institute to use TALEN to recode a human genome 2018-05-01
Crescendo Biologics–SEVERAL: investment, 201805 financing round Series B €57m led by Andera Partners 2018-04-30
LabCorp–Eurofins: investment, 201804– acquisition $670m cash/debt free of Covance Food Solutions from LabCorp by Eurofins 2018-04-30
EryDel–SEVERAL: investment, 201804 financing round €26.5m led by Sofinnova Partners + incl Genextra + Innogest SGR 2018-04-24
EryDel–Sofinnova: investment, 201804 financing round totalling €26.5m inc lead investor Sofinnova Partners 2018-04-24
Onxeo–LifeSci: public relations, 201804 service existent IR US by LifeSci Advisors 2018-04-24
Onxeo–NewCap: public relations, 201804 service existent IR + strategic communication by NewCap 2018-04-24
LimFlow–SEVERAL: investment, 201804 financing round Series C €27m led by Sofinnova Crossover I Fund 2018-04-16
Shire–Servier: investment, 201804– acquisition of Shire’s oncology business for $2.4b in cash by Servier ANNOUNCED 2018-04-16
Allecra Therapeutics–HC Wainwright: investor conference, 201804 supply service Allecra presents at HC Wainwright Global Life Sciences Conference 2018-04-08
Curetis–HC Wainwright: investor conference, 201804 supply service Curetis presents at HC Wainwright Global Life Sciences Conference in Monte Carlo 2018-04-08
Astute Medical–Mérieux: investment, 201804 acquisition $90m in cash by bioMérieux 2018-04-04
Boehringer–OSE Immunotherapeutics: antibody cancer drug, 201804– collab + license ww OSE-172 €30m upfront+short-term + €1.1b milestones + royalties 2018-04-04
LCF Rothschild–Andera Partners: investment, 201804 management buy-out of EdRIP by employees + renaming to Andera Partners 2018-04-04
Sofinnova–SEVERAL: investment, 201804 1st closing €275m of Sofinnova Crossover I fund 2018-04-04
Allogene Therapeutics–Cellectis: T-cell immunotherapy, 201804– collab continuation of Pfizer-Cellectis collaboration signed 201406 by Allogene 2018-04-03
Cellectis–SEVERAL: investment, 201804 public offering $175m ($163.7m net) with 5.646m ADSs at $31/ADS 2018-04-03
Young In Group–Eurofins: investment, 201804 acquisition of Lab Frontier Co Ltd from YIG by Eurofins 2018-04-03
Deinove–Redx Pharma: antibiotics, 201803– option + license agreem for Redx’ Novel Bacterial Topoisomerase Inhibitor programme 2018-03-22
DBV Technologies–SEVERAL: investment, 201803 global offering $172.5m public offering ADSs at $21.26 + private placement ordinary shares at €34.71 2018-03-20
Mérieux–Sartorius: bioreactors, 201803 supply of single-use viral vector manufacturing package to ABL Europe in Strasboug by SSB 2018-03-16
Valbiotis–Actifin: public relations, 201803 service financial communication existent by Actifin 2018-03-15
Valbiotis–Alize RP: public relations, 201803 service existent PR by Alize RP 2018-03-15
DBV Technologies–Barclays: investor conference, 201803 supply service DBV Technologies presents at Barclays Global Healthcare Conference 2018-03-14
Deinove–Naicons: antibiotics drug discovery, 201803– collab incl access to strain bank of Naicons 2018-03-08
Ventech–SEVERAL: investment, 201803 first closing €140m of Ventech Capital V fund with €200m target size 2018-03-07
NMDL-LCPL (NL)–Eurofins: investment, 201802 acquisition of NMDL-LCPL by Eurofins 2018-02-26
ASIT Biotech–SEVERAL: investment, 201802 private placement capital increase 2nd tranche €2.1m w 544k new shares at €3.83/share 2018-02-23
ASIT Biotech–SEVERAL: investment, 201802 warrant excercise €2.4m for 626k new shares at €3.83/share 2018-02-23
City Analysts–Eurofins: investment, 201802 acquisition of City Analysts Ltd by Eurofins 2018-02-23
Hybrigenics–Helixio: investment, 201802 management buy-out €na of Helixio from Hybrigenics 2018-02-19
BrainEver–iBionext: investment, 201802 existent investment by iBionext Growth Fund that co-created BrainEver 2018-02-14
Brainiac–iBionext: investment, 201802 existent investment by iBionext Growth Fund that co-created Brainiac 2018-02-14
Chronocam–iBionext: investment, 201802 existent investment by iBionext Growth Fund that co-created Chronocam 2018-02-14
Chronolife–iBionext: investment, 201802 existent investment by iBionext Growth Fund that co-created Chronolife 2018-02-14
iBionext–SEVERAL: investment, 201802 2nd + final closing of iBionext Growth Fund with additional €44m bringing total to €90m 2018-02-14
Tilak Healthcare–iBionext: investment, 201802 existent investment by iBionext Growth Fund that co-created Tilak 2018-02-14
Swiss Medical Imaging Investment–RAD-x: investment, 201802 acquisition of SMII by RAD-x 2018-02-13
BioMeca–Synthelis: proteomic services, 201802– collab joint services for production + folding validation of difficult-to-express proteins 2018-02-12
Nosopharm–Andrew Lloyd Associates: public relations, 201802 service existent by ALA 2018-02-12
Nosopharm–France (govt): credit, 201802– interest-free loan €1m for preclinical developm of NOSO-502 from Bpifrance 2018-02-12
LCF Rothschild–SEVERAL: investment, 201802 closing €345m of BioDiscovery 5 fund of EdRIP 2018-02-07
Servier–ImmunoQure: therapeutic antibodies, 201802– collab developm of INF-alpha human autoantibody for autoimmune diseases 2018-02-06
Labo Van Poucke–Eurofins: investment, 201802 acquisition of LVP by Eurofins 2018-02-05
Foundry Innovation & Research 1–SEVERAL: investment, 201801 financing round Series C €40m of FIRE1 led by new investor Gilde Healthcare 2018-01-30
Helsinn–Scientific Centre of Monaco: cancer drug, 201801– collab research new pharmacological inhibitors for clear cell renal cell carcinoma 2018-01-30
Ablynx–Sanofi: investment, 201801– acquisition recommended cash tender offer €3.9b with €45/share 2018-01-29
ASIT Biotech–SEVERAL: investment, 201801 private placement capital increase first tranche €9.4m w 2.46m new shares at €3.83/share 2018-01-25
Selcia–Eurofins: investment, 201801 acquisition of Selcia Ltd by Eurofins 2018-01-25
ImmuPharma–SEVERAL: investment, 201801 placing £10m of 6.945m new ordinary shares at 144p/share 2018-01-24
Craft Technologies–Eurofins: investment, 201802 acquisition of Craft Technologies Inc by Eurofins 2018-01-23
Bioverativ–Sanofi: investment, 201801–201803 acquisition cash tender offer $11.6b with $105/share 2018-01-22
Food Analytica (HU)–Eurofins: investment, 201801 acquisition by Eurofins 2018-01-18
Cellnovo–Flextronics: contract manufacturing, 201801 supply existent production of Cellnovo Diabetes Monitoring System + Cartridges by Flex 2018-01-17
HalioDx–SEVERAL: investment, 201801 financing round Series B €18.5m from new investors Bpifrance + Quest for Growth + Amundi + returning investors 2018-01-17
Novolyze–SEVERAL: grant, 201801 total of €1m public research programs + grants incl from French govt Investissement d’Avenir fund (LF) 2018-01-17
Novolyze–SEVERAL: investment, 201801 financing round €1.2m from private investors + family offices + business angels 2018-01-17
Sartorius–Synpromics: genomic technology, 201801 collab existent with Sartorius Stedim Cellca 2018-01-17
TxCell–France (govt): credit, 201801– interest-free PTZI loan €1.2m from Bpifrance 2018-01-17
Owkin–SEVERAL: investment, 201801 financing round Series A $11m led by Otium Venture + incl Cathay Innovation + Plug and Play + NJF Capital 2018-01-16
Pherecydes Pharma–SEVERAL: investment, 201801 financing round Series B €8.7m led by new investor Go Capital 2018-01-16
France (govt)–Mérieux: water analysis technology, 201801– collab extension to develop Acquapad by bioMérieux + CNES 2018-01-15
Tsing Hua Testing & Analysis–Eurofins: investment, 201801 acquisition by Eurofins Scientific 2018-01-15
Structural Genomics Consortium–Enamine: chemical compound libraries, 201801– supply new generation of Diamond-SGC-iNEXT (DSI) Poised Library 2018-01-10
Truffle Capital–Alize RP: public relations, 201801 service existent by Alize RP 2018-01-10
Truffle Capital–SEVERAL: investment, 201801 first closing €85m of Truffle BioMedTec fund with €200m target size in 2018 2018-01-10
Cellectis–JPMorgan Chase: investor conference, 201801 supply service Cellectis presents at JP Morgan Healthcare Conference 2018 2018-01-08
Enterome–BMS: investment, 201801 financing round Series D totalling €32m incl strategic investor BMS 2018-01-04
Enterome–BPCE: investment, 201801 financing round Series D totalling €32m incl existing investor Seventure + Health for Life Capital 2018-01-04
Enterome–EU (govt): credit, 201801– EIB loan facility €40m 2018-01-04
Enterome–Lundbeck: investment, 201801 financing round Series D totalling €32m incl existing investor LundbeckFonden Ventures 2018-01-04
Enterome–Nestlé: investment, 201801 financing round Series D totalling €32m incl existing investor Nestlé Health Science 2018-01-04
Enterome–Omnes Capital: investment, 201801 financing round Series D totalling €32m incl existing investor Omnes Capital 2018-01-04
Enterome–Principia SGR: investment, 201801 financing round Series D totalling €32m incl new investor Principia SGR 2018-01-04
Enterome–SEVERAL: investment, 201801 financing round Series D €32m incl Seventure + Health for Life Capital + Lundbeck Fonden + Omnes Capital et al 2018-01-04
Themis Bioscience–SEVERAL: investment, 201801 financing round Series C €10m led by new investor GHIF 2018-01-04
Clariant–Global Bioenergies: biopolymers, –201801 collab developm bio-based polymers for cosmetics developed w sugar-based isobutene 2018-01-02
ArteDrone–Truffle Capital: investment, 201801 Truffle BioMedTec fund is founding investor 2018-01-01
HoliStick Medical–Truffle Capital: investment, 201801 Truffle BioMedTec fund is founding investor 2018-01-01
Nanosive–Truffle Capital: investment, 201801 Truffle BioMedTec fund is founding investor 2018-01-01
Pasteur Group (BR)–Eurofins: investment, 201712 acquisition by Eurofins 2017-12-21
BPCE–Instinctif Partners: public relations, 201712 service existent for Seventure Partners by Instinctif Partners 2017-12-14
Discngine–Extens Développement e-Santé: investment, 201712 financing round Series A €1.1m from Extesn Dévelopmente e-Santé 2017-12-11
Hookipa Biotech–Forbion: investment, 201712 financing round Series C totalling €50m incl returning investor Forbion Capital Partners 2017-12-11
Hookipa Biotech–SEVERAL: investment, 201712 financing round Series C €50m led by undisclosed US public investment fund 2017-12-11
Hookipa Biotech–Sofinnova: investment, 201712 financing round Series C totalling €50m incl returning investor Sofinnova Partners 2017-12-11
Robocath–SEVERAL: investment, 201712 financing round €1.7m led by CAIT managed by Supernova Invest + incl Cardio Participation 2017-12-06
Advicenne–Huntsworth: public relations, 201712 service existent by Citigate Dewe Rogerson 2017-12-05
Qvella–Mérieux: investment, 201712 financing round Series B totallling $20m incl co-lead + new strategic investor bioMérieux 2017-12-04
Qvella–SEVERAL: investment, 201712 financing round Series B $20m co-led by new strategic investor bioMérieux + existing investor syndicate 2017-12-04
CLINGLIO project–EU (govt): grant, 201712–202011 Horizon 2020 grant €6.15m 3y for ph2 trial of 2OHOA in malignant glioma 2017-12-01
Irish Stock Exchange–Euronext: investment, 201711– acquisition €173m debt/cash free ANNOUNCED 2017-11-29
Abivax–Deutsche Börse: investor conference, 201711 supply service Abivax presents at Deutsches Eigenkapitalforum 2017 2017-11-28
Enyo Pharma–Charles River: drug discovery services, –201711 collab drug target identification of EYP002 using CCMS technology 2017-11-28
LIMA project–EU (govt): grant, 201711– Horizon 2020 grant €6.3m 4y Liquid biopsies and IMAging for improved cancer care 2017-11-23
Nicox–Infopro Digital: investor conference, 201709 supply service Nicox presents at Actionaria 2017 in Paris 2017-11-23
Advicenne–SEVERAL: investment, 201711–201801 IPO €27.8m w 1.925m+60k new shares at €14.03/share at Euronex Paris 2017-11-21
Dexstr–ChemAxon: cheminformatics, 201711– collab integration of ChemAxon s/w into Inquiro Scientific Knowledge Management System 2017-11-21
Ablynx–Bryan Garnier: investor conference, 201711 supply service Ablynx participates at Bryan Garnier Annual Healthcare Conference in Paris 2017-11-17
1 2 3 4 5 6 7 8 9 10 11 12  next pagenext page



Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

» top